Siemens Fonds Invest GmbH Invests $426,000 in Avantor, Inc. (NYSE:AVTR)

Siemens Fonds Invest GmbH bought a new stake in shares of Avantor, Inc. (NYSE:AVTR) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 20,213 shares of the company’s stock, valued at approximately $426,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in AVTR. MassMutual Private Wealth & Trust FSB boosted its holdings in Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after acquiring an additional 625 shares in the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Avantor by 106.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC increased its position in shares of Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after buying an additional 1,067 shares during the period. UMB Bank n.a. increased its position in shares of Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares during the period. Finally, AlphaQuest LLC bought a new position in Avantor in the fourth quarter worth about $65,000. Institutional investors own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on AVTR shares. Stifel Nicolaus cut Avantor from a “buy” rating to a “hold” rating and cut their price objective for the company from $26.00 to $14.00 in a research report on Monday, April 28th. Raymond James restated an “outperform” rating and issued a $24.00 target price (down previously from $26.00) on shares of Avantor in a research note on Monday, February 10th. Cowen cut Avantor from a “buy” rating to a “hold” rating in a research note on Monday, April 28th. Robert W. Baird decreased their price objective on Avantor from $21.00 to $17.00 and set an “outperform” rating for the company in a report on Monday, April 28th. Finally, Wells Fargo & Company lowered their price objective on Avantor from $25.00 to $22.00 and set an “overweight” rating for the company in a research report on Thursday, April 17th. Seven analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $18.88.

Avantor Trading Up 4.3%

Avantor stock opened at $13.40 on Friday. Avantor, Inc. has a 12 month low of $11.82 and a 12 month high of $28.00. The company has a market capitalization of $9.13 billion, a price-to-earnings ratio of 12.88, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09. The business’s fifty day simple moving average is $14.76 and its two-hundred day simple moving average is $18.59. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.23. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.61 billion. Avantor had a return on equity of 12.17% and a net margin of 10.49%. Avantor’s quarterly revenue was down 5.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.22 EPS. As a group, equities analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insider Buying and Selling at Avantor

In other news, Director Gregory L. Summe purchased 25,000 shares of the business’s stock in a transaction dated Wednesday, May 7th. The shares were purchased at an average price of $12.00 per share, for a total transaction of $300,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares in the company, valued at $600,000. This represents a 100.00% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP James Bramwell sold 3,758 shares of the firm’s stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now directly owns 87,379 shares of the company’s stock, valued at $1,531,753.87. This trade represents a 4.12% decrease in their position. The disclosure for this sale can be found here. 1.20% of the stock is owned by company insiders.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.